Cargando…
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study
BACKGROUND: Multiple sclerosis is a chronic, incurable, demyelinating disease that requires long-term treatment. Rates of non-adherence to prescribed therapy of up to 50% have been reported for chronic diseases. Strategies to improve treatment adherence are therefore of the utmost importance. This s...
Autores principales: | Zettl, Uwe K, Bauer-Steinhusen, Ulrike, Glaser, Thomas, Hechenbichler, Klaus, Limmroth, Volker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849232/ https://www.ncbi.nlm.nih.gov/pubmed/24011220 http://dx.doi.org/10.1186/1471-2377-13-117 |
Ejemplares similares
-
Comparative evaluation of patients’ and physicians’ satisfaction with interferon beta-1b therapy
por: Zettl, Uwe Klaus, et al.
Publicado: (2016) -
Assessment of Medication Adherence Using a Medical App Among Patients With Multiple Sclerosis Treated With Interferon Beta-1b: Pilot Digital Observational Study (PROmyBETAapp)
por: Limmroth, Volker, et al.
Publicado: (2019) -
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients
por: Hecker, Michael, et al.
Publicado: (2013) -
Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart(®) Injector: Results of the Prospective Cohort Study REBIFLECT
por: Rieckmann, Peter, et al.
Publicado: (2022) -
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program
por: Katsarava, Zaza, et al.
Publicado: (2015)